The JASMINE trial showed nipocalimab's efficacy in SLE, meeting primary and secondary endpoints, including steroid sparing ...

Early intensive BP control significantly reduces cardiovascular risk in older patients compared with delayed initiation of treatment.

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

A substantial percentage of adults with gout attribute their condition to lifestyle factors, which may lead to worse health outcomes and poorer SU control.

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Major depressive disorder (MDD) is a widespread and serious mental health condition that affects how people think, feel, and ...

It comes on the heels of the CDC Advisory Council on Immunization Practices eliminating long-standing recommendations for hepatitis B vaccines for newborns. Health Secretary Robert F. Kennedy Jr.

A new £50 million initiative aims to cut the length of time novel medicines spend in clinical trials, enabling patients to ...

Canada: Researchers have reported that a closed-loop insulin delivery system significantly improves glucose control during ...

Obexelimab met the primary endpoint demonstrating a clinically meaningful and highly statistically significant 56% reduction ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...